343 related articles for article (PubMed ID: 9693665)
1. Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia.
Harth Y; Hirshowitz B; Kaplan B
Dermatol Surg; 1998 Jul; 24(7):723-6. PubMed ID: 9693665
[TBL] [Abstract][Full Text] [Related]
2. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
4. Aminolevulinic acid photodynamic therapy for skin cancers.
Blume JE; Oseroff AR
Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
6. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
7. A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer.
Zeitouni NC; Paquette AD; Housel JP; Shi Y; Wilding GE; Foster TH; Henderson BW
Lasers Surg Med; 2013 Feb; 45(2):89-94. PubMed ID: 23390058
[TBL] [Abstract][Full Text] [Related]
8. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
[TBL] [Abstract][Full Text] [Related]
9. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
10. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy.
Morton CA; Whitehurst C; Moore JV; MacKie RM
Br J Dermatol; 2000 Oct; 143(4):767-72. PubMed ID: 11069454
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
[TBL] [Abstract][Full Text] [Related]
12. [Topical photodynamic therapy in treatment of superficial skin tumors].
Szeimies RM; Landthaler M
Hautarzt; 1995 May; 46(5):315-8. PubMed ID: 7607894
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy in combination with CO2 laser for the treatment of Bowen's disease.
Cai H; Wang YX; Zheng JC; Sun P; Yang ZY; Li YL; Liu XY; Li Q; Liu W
Lasers Med Sci; 2015 Jul; 30(5):1505-10. PubMed ID: 25899562
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy of epithelial skin tumours using delta-aminolaevulinic acid and desferrioxamine.
Fijan S; Hönigsmann H; Ortel B
Br J Dermatol; 1995 Aug; 133(2):282-8. PubMed ID: 7547399
[TBL] [Abstract][Full Text] [Related]
15. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.
Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J
Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of photodynamic therapy by use of aminolevulinic acid/glycolic acid drug mixture.
Ziolkowski P; Osiecka BJ; Oremek G; Siewinski M; Symonowicz K; Saleh Y; Bronowicz A
J Exp Ther Oncol; 2004 Jul; 4(2):121-9. PubMed ID: 15503395
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy for non-melanoma skin cancer.
Fien SM; Oseroff AR
J Natl Compr Canc Netw; 2007 May; 5(5):531-40. PubMed ID: 17509255
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.
Morton CA; Brown SB; Collins S; Ibbotson S; Jenkinson H; Kurwa H; Langmack K; McKenna K; Moseley H; Pearse AD; Stringer M; Taylor DK; Wong G; Rhodes LE
Br J Dermatol; 2002 Apr; 146(4):552-67. PubMed ID: 11966684
[TBL] [Abstract][Full Text] [Related]
19. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients.
Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA
G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909
[TBL] [Abstract][Full Text] [Related]
20. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer.
Cairnduff F; Stringer MR; Hudson EJ; Ash DV; Brown SB
Br J Cancer; 1994 Mar; 69(3):605-8. PubMed ID: 8123497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
